Figure S4 from A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study

Autor: Rajiv Raja, Vikram K. Chand, Kimberly C. Banks, Brandon W. Higgs, Koustubh Ranade, Philip Z. Brohawn, Naiyer A. Rizvi, Solange Peters, Urban Scheuring, Feng Liu, Jiabu Ye, Elena Helman, Katie J. Quinn, Michael Kuziora, Han Si
Rok vydání: 2023
DOI: 10.1158/1078-0432.22481495
Popis: GuardantOMNI assay success rates
Databáze: OpenAIRE